Group 1 - The negotiation for the 2025 National Medical Insurance Catalog and commercial insurance innovative drug catalog prices has officially started in Beijing, lasting 4 to 5 days, with some drugs applying for both basic medical insurance and commercial insurance catalogs [1][6] - Representatives from companies indicated that the price negotiation is quite tight, with limited room for price increases based on the offers from medical insurance negotiation representatives [1][3] Group 2 - The first day of negotiations involved multiple varieties of drugs, with some companies participating in both morning and afternoon sessions [4][6] - A significant number of foreign and domestic pharmaceutical companies are participating in the negotiations, including Pfizer, Boehringer Ingelheim, and various domestic firms such as Hunan Kelun Pharmaceutical and Jiangsu Kangyuan Pharmaceutical [6] - A total of 535 drugs passed the formal review for this round of negotiations, including 311 drugs from outside the catalog and 224 drugs from within the catalog, along with 121 high-value drugs approved for the commercial insurance innovative drug catalog [6]
现场直击 | 2025年国家医保谈判首日 有企业代表称价格“挺紧的”
Mei Ri Jing Ji Xin Wen·2025-10-30 15:19